Results 161 to 170 of about 12,312 (182)

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Proceedings of the National Academy of Sciences of the United States of America, 2018
Gv Thomas, Shannon Mcweeney, Dae-Hwan Kim   +2 more
exaly  

USE OF LSD1 INHIBITOR

2021
LI JIAYIN, LIN HONGMEI
openaire   +1 more source

Drug Design Concepts for LSD1‐Selective Inhibitors

Chemical Record, 2018
Takayoshi Suzuki, Yosuke Ota
exaly  

Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors

ACS Medicinal Chemistry Letters, 2017
Hong-Min Liu, Bin Yu, Yi-Chao Zheng
exaly  

LSD1 INHIBITORS AND USES THEREOF

2016
ALBRECHT BRIAN K, AUDIA JAMES EDMUND, CÔTÉ ALEXANDRE, DUPLESSIS MARTIN, GEHLING VICTOR S, HARMANGE JEAN-CHRISTOPHE, VASWANI RISHI G   +6 more
openaire   +4 more sources

The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer

Cancer Letters, 2016
Yanling Wang, Jianrong Yang
exaly  

Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers

International Journal of Cancer, 2011
Shinya Hayami, Yusuke Nakamura, Ryuji Hamamoto   +2 more
exaly  

LSD1 in drug discovery: From biological function to clinical application

Medicinal Research Reviews
Hong-Min Liu
exaly  

Triazolopyridines and triazolopyrazines as LSD1 inhibitors

2016
WU LIANGXING, WANG XIAOZHAO, YAO WENQING, ZHANG COLIN   +3 more
openaire   +4 more sources

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

2016
WU LIANGXING, KONKOL LEAH C, LAJKIEWICZ NEIL, LU LIANG, XU MEIZHONG, YAO WENQING, YU ZHIYONG, ZHANG COLIN, HE CHUNHONG   +8 more
openaire   +3 more sources